INmune Bio, Inc. (INMB) vs Nomad Power Solutions, Inc. (NMAD)

INmune Bio, Inc. and Nomad Power Solutions, Inc. are both Biotechnology companies. INmune Bio, Inc. and Nomad Power Solutions, Inc. are of similar size ($58.5M and $55.5M). Across the 9 metrics below, Nomad Power Solutions, Inc. leads on 7 and INmune Bio, Inc. on 2.

Valuation

Metric INMB NMAD Biotechnology median
P/E n/m n/m 7.88
P/S 401.77 n/m 11.47
P/B 2.66 1.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 301.47 n/m 10.73
Earnings yield (33.00%) (27.93%) (28.84%)
Free cash flow yield (30.30%) (11.31%) (23.03%)

Profitability

Metric INMB NMAD Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (74.82%) (68.04%) (57.72%)
Return on assets (57.08%) (62.67%) (49.22%)
Return on invested capital (646.94%) (40.41%) 0.00%

Growth

Metric INMB NMAD Biotechnology median
Revenue growth (TTM) (51.61%) — 5.64%
EPS growth (last fiscal year) 11.85% 20.75% —
Revenue growth, 5-year CAGR 35.37% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INMB NMAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.04 12.87 4.73
Net debt to EBITDA 0.52 1.00 0.96

Dividend

Metric INMB NMAD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric INMB NMAD Biotechnology median
Market cap 55.51m 58.45m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack